InsiderTrades.com logo
Adel Mekhail net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Adel Mekhail Biography and Net Worth

EVP, Marketing & Sales of Prestige Consumer Healthcare

Adel Mekhail joined Prestige Consumer Healthcare Inc. in May 2019 as Executive Vice President of Marketing & Sales, bringing 30+ years of extensive industry experience to lead the Company’s sales, marketing and product development initiatives. Prior to Prestige, over his career Mr. Mekhail has held several key leadership roles at various companies including Pfizer, Energizer, and most recently Edgewell Personal Care. Adel holds a B.A. in Pharmaceutical Sciences from Tanta University in Egypt and an MBA from RMIT University in Australia.

What is Adel Mekhail's net worth?

The estimated net worth of Adel Mekhail is at least $1.56 million as of November 12th, 2024. Mr. Mekhail owns 18,365 shares of Prestige Consumer Healthcare stock worth more than $1,561,282 as of March 29th. This net worth approximation does not reflect any other investments that Mr. Mekhail may own. Additionally, Mr. Mekhail receives a salary of $797,940.00 as EVP, Marketing & Sales at Prestige Consumer Healthcare. Learn More about Adel Mekhail's net worth.

How old is Adel Mekhail?

Mr. Mekhail is currently 63 years old. There are 3 older executives and no younger executives at Prestige Consumer Healthcare. Learn More on Adel Mekhail's age.

What is Adel Mekhail's salary?

As the EVP, Marketing & Sales of Prestige Consumer Healthcare Inc., Mr. Mekhail earns $797,940.00 per year. There are 2 executives that earn more than Mr. Mekhail. The highest earning executive at Prestige Consumer Healthcare is Mr. Ronald M. Lombardi, Chairman, President & CEO, who commands a salary of $1,980,000.00 per year. Learn More on Adel Mekhail's salary.

How do I contact Adel Mekhail?

The corporate mailing address for Mr. Mekhail and other Prestige Consumer Healthcare executives is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. Prestige Consumer Healthcare can also be reached via phone at (914) 524-6800 and via email at irinquiries@prestigebrands.com. Learn More on Adel Mekhail's contact information.

Has Adel Mekhail been buying or selling shares of Prestige Consumer Healthcare?

Adel Mekhail has not been actively trading shares of Prestige Consumer Healthcare in the last ninety days. Most recently, Adel Mekhail sold 9,063 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $82.00, for a transaction totalling $743,166.00. Following the completion of the sale, the executive vice president now directly owns 18,365 shares of the company's stock, valued at $1,505,930. Learn More on Adel Mekhail's trading history.

Who are Prestige Consumer Healthcare's active insiders?

Prestige Consumer Healthcare's insider roster includes Mary Beth Fritz (SVP), Ronald Lombardi (Insider), Adel Mekhail (EVP, Marketing & Sales), and William P'pool (SVP, General Counsel and Corporate Secretary). Learn More on Prestige Consumer Healthcare's active insiders.

Are insiders buying or selling shares of Prestige Consumer Healthcare?

In the last year, insiders at the sold shares 5 times. They sold a total of 40,488 shares worth more than $3,338,320.40. The most recent insider tranaction occured on March, 10th when SVP Mary Beth Fritz sold 1,678 shares worth more than $151,020.00. Insiders at Prestige Consumer Healthcare own 1.6% of the company. Learn More about insider trades at Prestige Consumer Healthcare.

Information on this page was last updated on 3/10/2025.

Adel Mekhail Insider Trading History at Prestige Consumer Healthcare

See Full Table

Adel Mekhail Buying and Selling Activity at Prestige Consumer Healthcare

This chart shows Adel Mekhail's buying and selling at Prestige Consumer Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Prestige Consumer Healthcare Company Overview

Prestige Consumer Healthcare logo
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More

Today's Range

Now: $85.01
Low: $84.52
High: $86.39

50 Day Range

MA: $83.30
Low: $75.35
High: $89.10

2 Week Range

Now: $85.01
Low: $62.35
High: $90.04

Volume

314,373 shs

Average Volume

271,302 shs

Market Capitalization

$4.21 billion

P/E Ratio

19.91

Dividend Yield

N/A

Beta

0.46